Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Id, Safronov"'
Publikováno v:
Europe PubMed Central
The peculiarities of development systemic inflammatory reactions during the chronic heart failure were studied in the research. The patients with different severity of the chronic heart failure and different clinical course were examined at the begin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8b0f241f9ac0613306435b176324474a
http://europepmc.org/abstract/med/19432220
http://europepmc.org/abstract/med/19432220
Autor:
At, Tepliakov, Sergey Shilov, En, Berezikova, Av, Efremov, Id, Safronov, Mg, Pustovetova, Sd, Maianskaia, Torim IuIu, Rs, Karpov
Publikováno v:
Europe PubMed Central
Aim of investigation - to study effect of angiotensin-converting enzyme (ACE) gene polymorphism as a dominant risk factor of development of chronic heart failure (CHF) and target for effective therapy with ACE inhibitor enalapril in patients with isc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::57bc8d48a9a14bb39e22306760e6b142
http://europepmc.org/abstract/med/23548421
http://europepmc.org/abstract/med/23548421
Autor:
At, Tepliakov, Sergey Shilov, En, Berezikova, Av, Efremov, Id, Safronov, Mg, Pustovetova, Sd, Maianskaia, Torim IuIu, Rs, Karpov
Publikováno v:
Europe PubMed Central
To study the impact of angiotensinogen (AGT) and angiotensin II receptor type 1 (AGTR1) gene polymorphisms on the development and course of chronic heart failure (CHF) in patients with coronary heart disease (CHD).Two hundred and twenty-six patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f4dbe619167e613d33e526b1f2f01979
http://europepmc.org/abstract/med/23536940
http://europepmc.org/abstract/med/23536940
Autor:
At, Tepliakov, Sergey Shilov, En, Berezikova, Torim IuIu, Av, Efremov, Id, Safronov, Sd, Maianskaia, Aa, Popova, En, Voronina, Rs, Karpov
Publikováno v:
Europe PubMed Central
To study beta1-adrenoceptor gene (ADRB1) polymorphism on the development and course of chronic heart failure (CHF) and on the efficiency of its treatment with the beta-adrenoblocker carvedilol in patients with coronary heart failure.Two hundred and t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::56256958b3b038deeb8fda37bfe6a929
http://europepmc.org/abstract/med/21516734
http://europepmc.org/abstract/med/21516734
Autor:
Teplyakov AT; Federal State Budgetary Science Institution 'Tomsk Research Institute of Cardiology of the Siberian Branch of the Russian Academy of Science'., Berezikova EN; State Budgetary Educational Institution of Higher Professional Education, 'Novosibirsk State Medical University' of the Ministry of Health of the Russian Federation., Shilov SN; State Budgetary Educational Institution of Higher Professional Education, 'Novosibirsk State Medical University' of the Ministry of Health of the Russian Federation., Efremova AV; State Budgetary Educational Institution of Higher Professional Education, 'Novosibirsk State Medical University' of the Ministry of Health of the Russian Federation., Pustovetova MG; State Budgetary Educational Institution of Higher Professional Education, 'Novosibirsk State Medical University' of the Ministry of Health of the Russian Federation., Popova AA; State Budgetary Educational Institution of Higher Professional Education, 'Novosibirsk State Medical University' of the Ministry of Health of the Russian Federation., Grakova EV; Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences., Torim YY; Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences., Safronov ID; State Budgetary Educational Institution of Higher Professional Education, 'Novosibirsk State Medical University' of the Ministry of Health of the Russian Federation., Andriyanova AV; Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences.
Publikováno v:
Kardiologiia [Kardiologiia] 2017 Oct; Vol. 57 (10), pp. 20-28.
Autor:
Teplyakov AT; Department of Heart Failure, Research Institute of Cardiology, Tomsk, Russia., Berezikova EN; Novosibirsk State Medical University, Ministry of Health of Russia, Novosibirsk, Russia., Shilov SN; Novosibirsk State Medical University, Ministry of Health of Russia, Novosibirsk, Russia., Grakova EV; Department of Heart Failure, Research Institute of Cardiology, Tomsk, Russia., Torim YY; Department of Heart Failure, Research Institute of Cardiology, Tomsk, Russia., Efremov AV; Novosibirsk State Medical University, Ministry of Health of Russia, Novosibirsk, Russia., Safronov ID; Novosibirsk State Medical University, Ministry of Health of Russia, Novosibirsk, Russia., Pustovetova MG; Novosibirsk State Medical University, Ministry of Health of Russia, Novosibirsk, Russia., Karpov RS; Department of Heart Failure, Research Institute of Cardiology, Tomsk, Russia.
Publikováno v:
Terapevticheskii arkhiv [Ter Arkh] 2015; Vol. 87 (4), pp. 8-12.
Autor:
Tepliakov AT, Shilov SN, Berezikova EN, Efremov AV, Safronov ID, Pustovetova MG, Maianskaia SD, Torim IuIu, Karpov RS
Publikováno v:
Terapevticheskii arkhiv [Ter Arkh] 2013; Vol. 85 (1), pp. 14-9.
Autor:
Tepliakov AT, Shilov SN, Berezikova EN, Efremov AV, Safronov ID, Pustovetova MG, Maianskaia SD, Torim IuIu, Karpov RS
Publikováno v:
Kardiologiia [Kardiologiia] 2013; Vol. 53 (3), pp. 9-14.
Publikováno v:
Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] [Antibiot Khimioter] 2012; Vol. 57 (3-4), pp. 29-32.
Publikováno v:
Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] [Antibiot Khimioter] 2012; Vol. 57 (9-10), pp. 25-7, 29-31.